| Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli MRA Karam, M Habibi, S Bouzari Molecular immunology 108, 56-67, 2019 | 235 | 2019 |
| Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern M Tabasi, MRA Karam, M Habibi, MS Yekaninejad, S Bouzari Osong public health and research perspectives 6 (4), 261-268, 2015 | 119 | 2015 |
| Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice MRA Karam, M Oloomi, M Mahdavi, M Habibi, S Bouzari Vaccine 31 (8), 1210-1216, 2013 | 95 | 2013 |
| Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran S Shahbazi, MRA Karam, M Habibi, A Talebi, S Bouzari Journal of global antimicrobial resistance 14, 118-125, 2018 | 71 | 2018 |
| Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria M Tabasi, MRA Karam, M Habibi, E Mostafavi, S Bouzari Journal of clinical and diagnostic research: JCDR 10 (12), DC01, 2016 | 71 | 2016 |
| Characterization of Antibiotic-Susceptibility Patterns, Virulence Factor Profiles and Clonal Relatedness in Proteus mirabilis Isolates from Patients with Urinary Tract … A Mirzaei, M Habibi, S Bouzari, MR Asadi Karam Infection and drug resistance, 3967-3979, 2019 | 48 | 2019 |
| Pasteurella multocida vaccine candidates: A systematic review S Mostaan, A Ghasemzadeh, S Sardari, MA Shokrgozar, GN Brujeni, ... Avicenna journal of medical biotechnology 12 (3), 140, 2020 | 47 | 2020 |
| Intranasal immunization with fusion protein MrpH· FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus … M Habibi, MRA Karam, MA Shokrgozar, M Oloomi, A Jafari, S Bouzari Molecular immunology 64 (2), 285-294, 2015 | 47 | 2015 |
| Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran KM Asadi, M Oloomi, M Habibi, S Bouzari Iranian journal of microbiology 4 (2), 55, 2012 | 47 | 2012 |
| Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of uropathogenic Escherichia coli MRA Karam, M Oloomi, M Mahdavi, M Habibi, S Bouzari Molecular immunology 54 (1), 32-39, 2013 | 44 | 2013 |
| Relationships between virulence factors and antimicrobial resistance among Escherichia coli isolated from urinary tract infections and commensal isolates in Tehran, Iran MRA Karam, M Habibi, S Bouzari Osong public health and research perspectives 9 (5), 217, 2018 | 43 | 2018 |
| Fabrication of cerium oxide nanoparticles by solution combustion synthesis and their cytotoxicity evaluation M Zarezadeh Mehrizi, S Ahmadi, R Beygi, M Asadi Russian Journal of Non-Ferrous Metals 59, 111-116, 2018 | 32 | 2018 |
| In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli S Hasanzadeh, M Habibi, MA Shokrgozar, R Ahangari Cohan, K Ahmadi, ... Scientific reports 10 (1), 16258, 2020 | 29 | 2020 |
| Antibiotic resistance, virulence and genetic diversity of Klebsiella pneumoniae in community- and hospital-acquired urinary tract infections in Iran F Eghbalpoor, M Habibi, O Azizi, MR Asadi Karam, S Bouzari Acta microbiologica et immunologica Hungarica 66 (3), 349-366, 2019 | 28 | 2019 |
| Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection M Habibi, MRA Karam, S Bouzari Microbial pathogenesis 110, 477-483, 2017 | 28 | 2017 |
| Detection and molecular characterization of Cryptosporidium species in recreational waters of Chaharmahal va Bakhtiyari province of Iran using nested-PCR-RFLP KM Naeini, M Asadi, MH Chaleshtori Iranian Journal of Parasitology 6 (1), 20, 2011 | 28 | 2011 |
| Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology S Aghaabdollahian, R Ahangari Cohan, D Norouzian, F Davami, ... Scientific reports 9 (1), 2978, 2019 | 26 | 2019 |
| A novel multi-peptide subunit vaccine admixed with AddaVax adjuvant produces significant immunogenicity and protection against Proteus mirabilis urinary tract infection in mice … E Choubini, M Habibi, A Khorshidi, A Ghasemi, MRA Karam, S Bouzari Molecular immunology 96, 88-97, 2018 | 25 | 2018 |
| Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus … M Habibi, MRA Karam, S Bouzari International Immunopharmacology 28 (1), 70-78, 2015 | 20 | 2015 |
| Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis M Habibi, MR Asadi Karam, S Bouzari Apmis 124 (6), 444-452, 2016 | 19 | 2016 |
